公开(公告)号：US11000538B2

公开(公告)日：2021-05-11

申请号：US16666586

申请日：2019-10-29

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong Deog Hong ,  Hyun Woo Jeong

IPC: A61K31/7048 ,  C07J17/00 ,  A61K9/00 ,  A61P21/06

Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent exercise ability enhancing effect and anti-fatigue effect.

公开(公告)号：US11000537B2

公开(公告)日：2021-05-11

申请号：US16656029

申请日：2019-10-17

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong Deog Hong ,  Hyun Woo Jeong

IPC: A61K31/7048 ,  A61P3/10 ,  C07J17/00

Abstract: The present specification relates to a composition containing novel ginsenoside, (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits excellent effects in glycemic control, lipid metabolic control, cholesterol control, anti-obesity and blood circulation improvement.

公开(公告)号：US10533206B2

公开(公告)日：2020-01-14

申请号：US15770019

申请日：2016-10-21

Applicant: AMOREPACIFIC CORPORATION

Inventor： Gi Baeg Nam ,  Dong Hyun Kim ,  Yong Deog Hong ,  Cheng Yi Zhang ,  Jun Seong Park

IPC: C12P33/16 ,  C12P19/44 ,  C07H17/00 ,  C07J17/00 ,  C12N9/24 ,  C12N9/42 ,  C12P33/20

Abstract: The present invention relates to a method for selectively producing compound K and compound Y, which are originally present in ginseng in a trace amount, from saponins of ginseng, and more specifically to a method capable of obtaining desired target compounds, that is, compound K and compound Y, in high yields, by treating saponins, obtained from ginseng, with particular enzymes to structurally convert the saponins.

公开(公告)号：US10519480B2

公开(公告)日：2019-12-31

申请号：US15769995

申请日：2016-10-21

Applicant: AMOREPACIFIC CORPORATION

Inventor： Gi Baeg Nam ,  Dong Hyun Kim ,  Yong Deog Hong ,  Jun Seong Park

IPC: C12P33/16 ,  C07H17/00 ,  C07J17/00 ,  C12P19/44

Abstract: The present invention relates to a method for selectively producing ginsenoside Rd, which is originally present in ginseng in a trace amount, from panaxadiol-type saponins of ginseng, and more specifically to a method capable of obtaining a desired target compound, that is, ginsenoside Rd, in high yields, by treating a panaxadiol-type saponin obtained from ginseng, with particular enzymes to structurally convert the saponins.

公开(公告)号：US11653665B2

公开(公告)日：2023-05-23

申请号：US16997591

申请日：2020-08-19

Applicant: AMOREPACIFIC CORPORATION

Inventor： Kwanghyun Shin ,  Wonkyung Cho ,  Jinoh Chung ,  Yong Deog Hong

IPC: A23F3/32 ,  A23F3/10 ,  B01J2/16 ,  B01J2/14

CPC classification number: A23F3/32 ,  A23F3/10 ,  B01J2/14 ,  B01J2/16

Abstract: Shown are a particulate processed product of tea and a method for preparing the same. The particulate processed product of tea has a sphericity S10 value of a particle corresponding to 10% cumulative subdistribution in cumulative distribution measured for the sphericity of tea particles of 0.68 or greater. The processed product of tea is convenient to drink because it is readily wetted and dispersed in water. In addition, it can be easily packaged and used due to a low angle of repose and thus excellent flowability.

公开(公告)号：US11633449B2

公开(公告)日：2023-04-25

申请号：US17179054

申请日：2021-02-18

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyungsu Kim ,  Si Young Cho ,  A Young Kim ,  Wonseok Park ,  Yong Deog Hong

IPC: A61K36/82 ,  A61K31/353 ,  A61P35/00 ,  A61P15/12 ,  A23L33/105 ,  A23L2/52 ,  A23L33/00

Abstract: The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.

公开(公告)号：US11612172B2

公开(公告)日：2023-03-28

申请号：US16664272

申请日：2019-10-25

Applicant: AMOREPACIFIC CORPORATION

Inventor： Kwanghyun Shin ,  Wonkyung Cho ,  Jinoh Chung ,  Yong Deog Hong

IPC: A23F3/32 ,  A23F3/14 ,  A23L19/00

Abstract: The present disclosure shows a particulate processed product of tea with quick dispersibility in water and a method for manufacturing a particulate processed product of tea. The processed product of tea comprises 20% by weight or less of fine powders having a particle diameter of 75 μm or less based on the total weight of the tea particles. The manufacturing method comprises the step of manufacturing tea particles using a fluid-bed rotor granulator having a rotor disc. The processed product of tea has quick wettability and dispersibility in water and thus is easy to drink. Also, the processed product of tea has a low angle of repose and thus has excellent flowability, so that it is easy to pack and use.

公开(公告)号：US11576923B2

公开(公告)日：2023-02-14

申请号：US17031147

申请日：2020-09-24

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong Deog Hong ,  Hyun Woo Jeong

IPC: A61K36/00 ,  A61K31/704 ,  A61K36/258 ,  A61Q19/08 ,  A61K8/63 ,  A61P17/00 ,  A61K8/97

Abstract: The present disclosure relates to a composition comprising (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for improving skin elasticity or skin wrinkles, which comprises administering an effective amount of (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof has a superior effect of improving skin elasticity and skin wrinkles.

公开(公告)号：US10265299B2

公开(公告)日：2019-04-23

申请号：US15561591

申请日：2016-03-30

Applicant: Amorepacific Corporation

Inventor： Seung Hyun Shin ,  Yong Deog Hong ,  Jun Seong Park ,  Yong Joo Na

IPC: A61K31/37 ,  A61Q7/00 ,  A61K8/49 ,  A61K9/00 ,  A61Q5/00 ,  A61Q5/02 ,  A61Q5/12

Abstract: The present invention relates to a composition for promoting hair growth and hair restoration containing psoralidin or a derivative thereof, which can be widely used as an external skin preparation for promoting hair growth and hair restoration, a cosmetic composition or a pharmaceutical composition, as the composition has high stability for skin without side effects and is very effective in promoting hair growth or preventing hair loss by activating stem cells.

公开(公告)号：US12252508B2

公开(公告)日：2025-03-18

申请号：US17267666

申请日：2019-06-27

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong Deog Hong ,  Hyun Woo Jeong

IPC: C07J17/00 ,  A23L33/105 ,  A61K8/63 ,  A61K9/00 ,  A61K31/704 ,  A61Q19/00 ,  C07H15/256

Abstract: The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.